ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
20.96
+0.30 (1.45%)
Nov 19, 2024, 4:00 PM EST
ZIVO Bioscience Revenue
ZIVO Bioscience had revenue of $31.50K in the quarter ending September 30, 2024, with 166.95% growth. This brings the company's revenue in the last twelve months to $79.02K, up 398.55% year-over-year. In the year 2023, ZIVO Bioscience had annual revenue of $27.65K.
Revenue (ttm)
79.02K
Revenue Growth
+398.55%
P/S Ratio
n/a
Revenue / Employee
9.88K
Employees
8
Market Cap
74.10M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
ZIVO Bioscience News
- 3 months ago - Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO) - GuruFocus
- 3 months ago - ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens - Business Wire
- 4 months ago - Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience's Coccidiosis Treatment in Broiler Chickens - Business Wire
- 10 months ago - ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study - Business Wire
- 10 months ago - ZIVO Bioscience Announces Uplisting to OTCQB Market - Business Wire
- 10 months ago - ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens - Business Wire
- 1 year ago - ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens - Business Wire
- 1 year ago - ZIVO Bioscience Announces Reverse Stock Split - Business Wire